ArticleJournal of cancer research and clinical oncology2023

Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma.

Yoon Jung Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.